L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers
Download in electronic PDF format for $75
Abstract: Diabetic foot ulcers are the most common cause of nontraumatic amputations and are responsible for 25% of all hospitalizations of patients with diabetes. Poor blood flow due to vascular endothelial dysfunction is considered the underlying cause of this condition. L-arginine is converted in the body to nitric oxide, a potent vasodilator, so supplementation with it may help increase vascular blood flow to ulcerated areas. Ascorbic acid has also been shown to improve endothelial-dependent vasodilation in diabetic patients. Together these nutrients may aid healing of diabetic foot ulcers. The author discusses physiology and topical treatment of diabetic foot ulcers. She then briefly describes ingredients in two sample formulations included with the article that may be of assistance, L-Arginine and Ascorbic Acid Hydrating Ulcer Gel, and L-Arginine and Ascorbic Acid in PLO (L-arginine, ascorbic acid, zinc sulfate, methylcellulose, propylene glycol, methylparaben, purified water, poloxamers, lecithin and isopropyl palmitate). She concludes that use of an appropriate topical dressing to treat diabetic foot ulcers can accelerate healing. While further studies are needed to determine the benefit from L-arginine and ascorbic acid, sufficient data exist to imply benefits for the diabetic patient.
Related Keywords:
diabetic foot ulcers, amputations, L-arginine, dry wound, wet wound, PLO gel, ascorbic acid, zinc sulfate, astringent antiseptic, antioxidant, vasodilator, methylcellulose, propylene glycol, methylparaben, purified water, poloxamers, lecithin, isopropyl palmitate
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers
Gorman Shellie
|
Mar/Apr 2000
Pg. 94-96
|
Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
|
Jul/Aug 2004
Pg. 265-267
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Riepl Mike
|
May/Jun 2020
Pg. 182-186
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 278-281
|
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
|
Jan/Feb 2017
Pg. 22-27
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
Options in Wound Care
Kincaid Michele R
|
Mar/Apr 2002
Pg. 92-95
|
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
McElhiney Linda F
|
Nov/Dec 2004
Pg. 458-460
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center
Vail Jane
|
Jan/Feb 2003
Pg. 21-23
|
Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom, Thompson Chad
|
Nov/Dec 2024
Pg. 455-458
|
Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 309-310
|
The Clinical Pharmacist's Role in Compounding for the Diabetic Patient
Harshbarger Robert, Harshbarger Diana
|
Mar/Apr 2000
Pg. 84-87
|
Ascorbic Acid 10% in Anhydrous PEG ointment
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 53
|
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
|
Nov/Dec 2022
Pg. 480-488
|
Ascorbic acid 5% Topical Microemulsion
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 423
|
Ascorbic Acid 250-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 240
|
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
|
Mar/Apr 2022
Pg. 94-98
|
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
|
Sep/Oct 2022
Pg. 364-368
|
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 410
|
Return to Top |